Alan S. Cross

12.4k citations
220 papers · 8.9k indexed · h-index 56

Alan S. Cross

215 papers receiving 8.5k citations

Peers

Alan S. Cross
Comparison fields: 5 of 144
  • Endocrinology 1.3k
  • Molecular Medicine 1.2k
  • Microbiology 1.0k
  • Immunology 3.1k
  • Critical Care and Intensive Care Medicine 631
Replace Alice Prince with:
Alice Prince United States
Joshua Fierer United States
Gerd Döring Germany
Theodore J. Standiford United States
David P. Speert Canada
Jeanine P. Wiener-Kronish United States
Kazuhiro Tateda Japan
Reuben Ramphal United States
Norbert Suttorp Germany
David C. Morrison United States
Alan S. Cross relative to Alice Prince United States Alice Prince's profile →
Citations per field
00.5×1.5×2.1×
Alice Prince · 1×
Citations per year

Countries citing papers authored by Alan S. Cross

Since Specialization
Citations

This map shows the geographic impact of Alan S. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan S. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan S. Cross more than expected).

Fields of papers citing papers by Alan S. Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan S. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan S. Cross. The network helps show where Alan S. Cross may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan S. Cross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan S. Cross Line = papers co-authored together Alan S. Cross links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20236
3 20238
4 202129
5 201811
6 201871
7 201459
8 20140
9 201430
10 201275
11 2008118
12 200874
13 200715
14 200651
15 200628
16 2006116
17 200570
18 200229
19 200120
20 198059

About Alan S. Cross

Alan S. Cross is a scholar working on Endocrinology, Molecular Medicine and Microbiology, having authored 220 papers that have together received 8.9k indexed citations. Recurring topics across this work include Immune Response and Inflammation (75 papers), Escherichia coli research studies (37 papers), Antibiotic Resistance in Bacteria (33 papers), Glycosylation and Glycoproteins Research (24 papers), Bacterial Infections and Vaccines (23 papers), Pneumonia and Respiratory Infections (20 papers), Sepsis Diagnosis and Treatment (20 papers) and Bacillus and Francisella bacterial research (17 papers). The work is most often cited by research in Endocrinology (1.3k citations), Molecular Medicine (1.2k citations) and Microbiology (1.0k citations). Alan S. Cross has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Jerald Sadoff, Steven M. Opal, P. Gemski, Brenda Roup, Dhananjaya V. Kalvakolanu, Jeffrey D. Hasday, N M Kelly, Thomas Held, Stanley J. Cryz and Matthias Trautmann. Their work appears in journals such as Infection and Immunity, The Journal of Infectious Diseases, Vaccine, The Journal of Immunology and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026